Copertina

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jules M. Janssen Daalen, Djoeke Doesburg, Liesbeth Hunik, Rogier Kessel, Thomas Herngreen, Dennis Knol, Thony Ruys, Bart J.F. van den Bemt, Henk J. Schers
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy
di: Fatima Zahra Marok, et al.
Pubblicazione: (2024)

Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter
di: Amy C.D. Peeters, et al.
Pubblicazione: (2025)

Machine Learning Prediction of Unbound Ceftriaxone Concentrations in Children: Capturing Developmental Changes in Protein Binding for Precision Dosing
di: Bo‐Hao Tang, et al.
Pubblicazione: (2026)

Clinical Trial: Immunogenicity of Double‐Dose Versus Standard‐Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease
di: Anupam Kumar Singh, et al.
Pubblicazione: (2025)

AI ‐Enabled Precision Dosing in Pediatrics: Enhancing Model‐Informed Decision Making
di: Kei Irie, et al.
Pubblicazione: (2026)

A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization
di: Ling Xue, et al.
Pubblicazione: (2024)

Model‐Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
di: Rashudy F. Mahomedradja, et al.
Pubblicazione: (2025)

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
di: Sten Hanke, et al.
Pubblicazione: (2025)

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients
di: Zachary L. Taylor, et al.
Pubblicazione: (2026)

Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
di: Helga Gardarsdottir, et al.
Pubblicazione: (2025)

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment
di: Nikki de Rouw, et al.
Pubblicazione: (2025)

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
di: Mira G.P. Zuidgeest, et al.
Pubblicazione: (2025)

A Comprehensive CYP2D6 Drug–Drug–Gene Interaction Network for Application in Precision Dosing and Drug Development
di: Simeon Rüdesheim, et al.
Pubblicazione: (2025)

Better Rejection‐Free Survival at Three Years in Kidney Transplant Recipients With Model‐Informed Precision Dosing of Mycophenolate Mofetil
di: Claire Villeneuve, et al.
Pubblicazione: (2024)

Assessment of Dosing Strategies for Pediatric Drug Products
di: Zachary L. Taylor, et al.
Pubblicazione: (2024)

Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses
di: Thomas M. Polasek, et al.
Pubblicazione: (2024)

Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
di: Prateek Sharma, et al.
Pubblicazione: (2025)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial
di: Yu Yang, et al.
Pubblicazione: (2024)

CB1 Receptor Antagonist Selonabant (ANEB‐001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial
di: Andriy A. Gorbenko, et al.
Pubblicazione: (2025)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply
di: Nauzer Forbes, et al.
Pubblicazione: (2024)

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial
di: Dave Singh, et al.
Pubblicazione: (2025)

Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing
di: Gauri G. Rao, et al.
Pubblicazione: (2024)

A User‐Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline
di: Charlotte Koldeweij, et al.
Pubblicazione: (2024)

Editorial: UDCA Dosing in PBC—Between Guideline Adherence and Clinical Reality: Authors' Reply
di: Ellen Werner, et al.
Pubblicazione: (2026)

Therapeutic exchange of angiotensin II receptor antagonists in patients hospitalised in a traumatology unit
di: J.F. Márquez-Peiró
Pubblicazione: (2009)

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
di: Ruben Malmberg, et al.
Pubblicazione: (2025)

Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3‐Way Crossover Trial
di: Andriy A. Gorbenko, et al.
Pubblicazione: (2025)

The Type of Follicle‐Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta‐Analysis
di: Toni J.F. Michael, et al.
Pubblicazione: (2025)

Low‐Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real‐World Study in China
di: Wenlong Yang, et al.
Pubblicazione: (2026)

Longitudinal Tumor Size and Survival Modeling for Exposure–Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer
di: Emmanuel Chigutsa, et al.
Pubblicazione: (2026)

Moving the Needle for Oncology Dose Optimization: A Call for Action
di: Karthik Venkatakrishnan, et al.
Pubblicazione: (2024)

Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
di: Karen Rowland Yeo, et al.
Pubblicazione: (2024)

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
di: Judith Y. M. N. Derijks‐Engwegen, et al.
Pubblicazione: (2024)

Safety, Pharmacokinetics, and Pharmacodynamics of a First‐in‐Class ClC‐1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial
di: Titia Q. Ruijs, et al.
Pubblicazione: (2024)

Establishment of the Drug Exposure Models in the Dosing Environment of Inhaled Preparations and Discussion on Contamination Prevention and Control Measures in the Dosing Procedure
di: Dan Zhang, et al.
Pubblicazione: (2026)

Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
di: Peter N. Morcos, et al.
Pubblicazione: (2024)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
di: Mariam A. Ahmed, et al.
Pubblicazione: (2024)

Editorial: UDCA Dosing in PBC – Between Guideline Adherence and Clinical Reality
di: Helena Hernández‐Évole, et al.
Pubblicazione: (2026)

Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
di: Andrew B. SyBing, et al.
Pubblicazione: (2025)

Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease
di: Nicholas Clark, et al.
Pubblicazione: (2025)